U.S. FDA approves Lexicon Pharma’s drug for heart failure
By Khushi Mandowara (Reuters) -The U.S. Food and Drug Administration (FDA) has approved Lexicon Pharmaceuticals Inc’s drug for a broad treatment of heart failure, including in adult patients with type 2 diabetes, the company said on Friday. Shares of the company rose 13% in extended trading. The oral drug, sotagliflozin, is the company’s first to…
